VIVO  valuation analysis

Basics
Name: Meridian Bioscience, Inc
Description: Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. (more)
Industry: Diagnostics & Research
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 05, 2021
Market cap: $1.03B (1247th)
Sales(TTM): $299.16M (1307th)
Earnings(TTM): $70.14M (836th)

Value
FFER: 0.53 (why)
Actual price: $23.94
FFEThis is Meridian Bioscience, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $46.72
Quantile: VIVO is very cheap given its fundamentals.
Prices as of EOD 2021-04-14
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Meridian Bioscience, Inc
"Diagnostics & Research" industry
Sales / MarketCap
Meridian Bioscience, Inc
"Diagnostics & Research" industry
Book / MarketCap
Meridian Bioscience, Inc
"Diagnostics & Research" industry
Equity / Assets
Meridian Bioscience, Inc
"Diagnostics & Research" industry